Representativeness of Peripheral Artery Disease Randomized Clinical Trials Supporting Current Guidelines
- 27 June 2023
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 201, 166-169
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Contemporary Trends in Hospital Admissions and Outcomes in Patients With Critical Limb IschemiaCirculation: Cardiovascular Quality and Outcomes, 2021
- Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical TrialsJAMA Cardiology, 2020
- Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysisThe Lancet Global Health, 2019
- Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular DrugsJACC, 2018
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive SummaryJACC, 2017
- Pragmatic TrialsNew England Journal of Medicine, 2016
- Underrepresentation of Women, Elderly Patients, and Racial Minorities in the Randomized Trials Used for Cardiovascular GuidelinesJAMA Internal Medicine, 2014
- Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysisThe Lancet, 2013
- Sex Differences in Perceived Risks, Distrust, and Willingness to Participate in Clinical TrialsArchives of internal medicine (1960), 2007
- Ethnic-Specific Prevalence of Peripheral Arterial Disease in the United StatesAmerican Journal of Preventive Medicine, 2007